These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24167614)

  • 1. Triple negative breast tumors in African-American and Hispanic/Latina women are high in CD44+, low in CD24+, and have loss of PTEN.
    Wu Y; Sarkissyan M; Elshimali Y; Vadgama JV
    PLoS One; 2013; 8(10):e78259. PubMed ID: 24167614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer.
    Wu Y; Mohamed H; Chillar R; Ali I; Clayton S; Slamon D; Vadgama JV
    Breast Cancer Res; 2008; 10(1):R3. PubMed ID: 18184439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of PTEN in high grade advanced stage triple negative breast ductal cancers in African American women.
    Khan F; Esnakula A; Ricks-Santi LJ; Zafar R; Kanaan Y; Naab T
    Pathol Res Pract; 2018 May; 214(5):673-678. PubMed ID: 29653745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Baseline Serum PD-L1 Level May Predict Poor Outcomes from Breast Cancer in African-American and Hispanic Women.
    Wu Y; Dutta P; Clayton S; McCloud A; Vadgama JV
    J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35053979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ALDH1A1 in contributing to breast tumour aggressiveness: A study conducted in an African population.
    Gyan E; Green A; Ahenkorah-Fondjo L; Jackson A; Toss MS; Akakpo PK; Derkyi-Kwarteng L; Rahman GA; Owiredu W
    Ann Diagn Pathol; 2021 Apr; 51():151696. PubMed ID: 33460998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients.
    Giatromanolaki A; Sivridis E; Fiska A; Koukourakis MI
    Med Oncol; 2011 Sep; 28(3):745-52. PubMed ID: 20405247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the racial heterogeneity of breast cancer stem cells.
    Gyan E; Owiredu WKBA; Fondjo LA; Jackson AM; Green AR; Rahman GA
    Gene; 2021 Sep; 796-797():145805. PubMed ID: 34197949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma.
    Lin Y; Zhong Y; Guan H; Zhang X; Sun Q
    J Exp Clin Cancer Res; 2012 Jul; 31(1):59. PubMed ID: 22762532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CD44 and CD24 phenotype with lymph node metastasis and survival in triple-negative breast cancer.
    Zou W; Yang Y; Zheng R; Wang Z; Zeng H; Chen Z; Yang F; Wang J
    Int J Clin Exp Pathol; 2020; 13(5):1008-1016. PubMed ID: 32509072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma.
    Zheng Z; Shao N; Weng H; Li W; Zhang J; Zhang L; Yang L; Ye S
    Med Oncol; 2015 Jan; 32(1):275. PubMed ID: 25429827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44/CD24 as potential prognostic markers in node-positive invasive ductal breast cancer patients treated with adjuvant chemotherapy.
    Adamczyk A; Niemiec JA; Ambicka A; Mucha-Małecka A; Mituś J; Ryś J
    J Mol Histol; 2014 Feb; 45(1):35-45. PubMed ID: 23835592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
    Chen Y; Song J; Jiang Y; Yu C; Ma Z
    Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
    Honeth G; Bendahl PO; Ringnér M; Saal LH; Gruvberger-Saal SK; Lövgren K; Grabau D; Fernö M; Borg A; Hegardt C
    Breast Cancer Res; 2008; 10(3):R53. PubMed ID: 18559090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pilot study on the correlation between high incidence of CD44+/CD24 -/low/ABCG2- cells and poor prognosis in breast cancer].
    Gong JF; Yuan YH; Song GH; Yu J; Han Y; Jia J; Ren J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):465-70. PubMed ID: 18931706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are CD44
    Ryspayeva DE; Smolanka II; Dudnichenko АS; Lyashenko AA; Grinevich YA; Gurianov VG; Koshubarova MV; Seleznev AA
    Exp Oncol; 2017 Sep; 39(3):224-228. PubMed ID: 28967636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer.
    Iqbal J; Thike AA; Cheok PY; Tse GM; Tan PH
    Histopathology; 2012 Oct; 61(4):652-9. PubMed ID: 22759273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metalloprotease-dependent activation of EGFR modulates CD44
    Wise R; Zolkiewska A
    Breast Cancer Res Treat; 2017 Nov; 166(2):421-433. PubMed ID: 28791489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer.
    Bernardi MA; Logullo AF; Pasini FS; Nonogaki S; Blumke C; Soares FA; Brentani MM
    Oncol Rep; 2012 Jan; 27(1):28-38. PubMed ID: 21956537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of autophagy protein LC3 and stemness (CD44+/CD24-/low) indicate poor prognosis in triple-negative breast cancer.
    Chang SJ; Ou-Yang F; Tu HP; Lin CH; Huang SH; Kostoro J; Hou MF; Chai CY; Kwan AL
    Hum Pathol; 2016 Feb; 48():48-55. PubMed ID: 26772398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics.
    Nahleh Z; Otoukesh S; Mirshahidi HR; Nguyen AL; Nagaraj G; Botrus G; Badri N; Diab N; Alvarado A; Sanchez LA; Dwivedi AK
    Cancer Med; 2018 Jun; 7(6):2710-2717. PubMed ID: 29733543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.